15 research outputs found

    Combined results of release and exposure assessments, and results of the sensitivity analysis on proxy indicators’ weights.

    No full text
    <p>Scatter plot of the overall release and exposure risk scores for the European Union member states, and the 80% central interquartile range of risk scores resulting from varying proxy indicators’ weights. Abbreviations – AT: Austria, BE: Belgium, BG: Bulgaria, CY: Cyprus, CZ: Czech Republic, DK: Denmark, EE: Estonia, FI: Finland, FR: France, DE: Germany, EL: Greece, HU: Hungary, IE: Ireland, IT: Italy, LV: Latvia, LT: Lithuania, LU: Luxembourg, MT: Malta, NL: Netherlands, PL: Poland, PT: Portugal, RO: Romania, SK: Slovakia, SI: Slovenia, ES: Spain, SE: Sweden, UK: United Kingdom.</p

    Detection of African Swine Fever Virus Antibodies in Serum and Oral Fluid Specimens Using a Recombinant Protein 30 (p30) Dual Matrix Indirect ELISA - Fig 2

    No full text
    ASFV recombinant p30 antibody ELISA sample-to-positive (S/P) responses in (2A) individual pig serum (mean, SE) and (2B) pen-based oral fluid samples following inoculation with replicon particle (RP) vaccines expressing ASFV p30 or a combination of ASFV p30/54/72. Controls were defined as unvaccinated pigs (one pen of 4 pigs) and pigs inoculated with RP vaccines expressing ASFV p54 (one pen of 8 pigs) or ASFV p72 (one pen of 8 pigs). In all cases, pigs received two doses of vaccine (days 0 and 21).</p
    corecore